CN100387256C - Medicine for treating gastric, anal and intestinal diseases - Google Patents
Medicine for treating gastric, anal and intestinal diseases Download PDFInfo
- Publication number
- CN100387256C CN100387256C CNB2004100257036A CN200410025703A CN100387256C CN 100387256 C CN100387256 C CN 100387256C CN B2004100257036 A CNB2004100257036 A CN B2004100257036A CN 200410025703 A CN200410025703 A CN 200410025703A CN 100387256 C CN100387256 C CN 100387256C
- Authority
- CN
- China
- Prior art keywords
- grams
- medicine
- gram
- stomach
- fructus fici
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a medicine for treating gastric, anal and intestinal diseases. The medicine is mainly prepared from fresh figs, licorice roots and honey according a definite weight mixture ratio, and can be prepared into any common oral preparation. The medicine has the functions of strengthening stomachs, cleaning intestines, eliminating tumefaction, removing toxicity, nourishing Zhong, replenishing qi, etc. The medicine has quick effect and high cure rate in treating stomach ache, stomach distention, sour regurgitation, constipation, hemorrhoid, dysentery, etc.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of the stomach anal and intestinal disease, belong to the field of Chinese medicines.
Background technology
The stomach anal and intestinal disease is a kind of common frequently-occurring disease, according to relevant reports of newspaper, world resident the intestines and stomach PMR is quite high, accounts for total population more than 30%, just the gastroenteropathy patient more than 300,000,000 is arranged approximately in China, the stomach anal and intestinal disease has a strong impact on human life quality and physical and mental health.At present, modern clinically Chinese and western medical science still lacks tangible specific aim treatment and specific medicine to the stomach anal and intestinal disease.
Summary of the invention
Therefore, people still have urgent demand to the medicine of treatment stomach anal and intestinal disease that better curative effect is arranged.Up to now, also do not find the report of any relevant drug regimen of the present invention, do not have the report of discovery and curative effect of medication of the present invention and the close plan of purposes yet.The inventor is through the research repeatedly more than 8 years, and verifies repeatedly by more than 2,000 patients' clinical treatment, found finally to have the oral medicinal herb medicine of stomach anal and intestinal disease evident in efficacy rapidly that takes effect, thereby finished the present invention.
The object of the invention just provides a kind of a kind of Chinese medicine composition of more effectively treating the stomach anal and intestinal disease.
Medicament selection Fructus Fici of the present invention, Mel, Radix Glycyrrhizae make up, and make each efficacy of drugs produce synergism these drug regimens, thereby can effectively and apace treat the stomach anal and intestinal disease comprehensively.Wherein select for use Fructus Fici to be because the Fructus Fici nature and flavor are sweet flat, invigorating the stomach and promoting bowel movement, subduing swelling and detoxicating, treatment dysentery, constipation, hemorrhoid, and also the single Fructus Fici just has curative effect preferably to the stomach anal and intestinal disease.Cooperate Radix Glycyrrhizae, Mel to be because the Radix Glycyrrhizae nature and flavor are sweet puts down and middle emergency, coordinating the actions of various ingredients in a prescription is controlled weakness of the spleen and stomach, peptic ulcer; The Mel nature and flavor are sweet flat, and invigorating middle warmer is moisturized, and can control the dryness of the intestine constipation, gastral cavilty swells and ache, and strengthen Fructus Fici bowel relieving nourishing the stomach, control the function of hemorrhoid.
In order to reach better therapeutic, the present invention also makes up with Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae.This is that invigorating the spleen and replenishing QI can be controlled weakness of the spleen and stomach, the chronic diarrhea proctoptosis because the Radix Codonopsis nature and flavor are sweet flat.The Rhizoma Atractylodis Macrocephalae is sweet in flavor and warm in property, benefit stomach stomach reinforcing, controls deficient QI of the spleen and stomach, anorexia, and deficiency-distension is had loose bowels.We reuse the Fructus Fici bowel relieving is good for the stomach and is monarch drug, Radix Codonopsis, and invigorating the spleen and replenishing QI, it is ministerial drug that the Rhizoma Atractylodis Macrocephalae is mended the stomach stomach reinforcing.Assistant is moisturized with the Mel invigorating middle warmer.The sweet temperature QI invigorating of Radix Glycyrrhizae, coordinating the actions of various ingredients in a prescription is for making.Five medicine compatibilities reach the good function of controlling stomach, nourishing the stomach, bowel relieving, controlling hemorrhoid.
In order to obtain optimum curative effect, medicine of the present invention also can add the Radix Astragali, Poria on the basis of said medicine.This is that invigorating the spleen and replenishing QI can be controlled diarrhea due to hypofunction of the spleen because of Radix Astragali sweet in the mouth slightly warm in nature.The Poria sweet in the mouth is flat, beneficial breast stomach function regulating, and the swelling of harnessing the river is full, and the sound of vomiting of vomitting is had loose bowels.With this seven flavor medicine combination, treatment stomach anal and intestinal disease has complementary functions, and effect is stronger, and it is faster to take effect, curative effect the best of treatment stomach anal and intestinal disease.
The consumption of drug component of the present invention also is that inventor's process gropes to sum up to draw for a long time in a large number, all has in the scope of each amounts of components infra column weight amount unit gram and treats cold effect preferably.
Fructus Fici fresh fruit 400-700 gram, Radix Glycyrrhizae 3-6 gram, Mel 15-25 gram.
Be preferably: Fructus Fici fresh fruit 600 grams, Radix Glycyrrhizae 5 grams, Mel 20 grams.
Each amounts of components of medicine of the present invention can also be: Fructus Fici fresh fruit 400-700 gram, Radix Codonopsis 12-16 gram, Rhizoma Atractylodis Macrocephalae 8-12 gram, Radix Glycyrrhizae 3-6 gram, Mel 15-25 gram.
Be preferably: Fructus Fici fresh fruit 600 grams, Radix Codonopsis 15 grams, the Rhizoma Atractylodis Macrocephalae 10 grams, Radix Glycyrrhizae 5 grams, Mel 20 grams.
The further each component consumption of medicine of the present invention is: Fructus Fici fresh fruit 400-700 gram, Radix Codonopsis 12-16 gram, Rhizoma Atractylodis Macrocephalae 8-12 gram, Radix Astragali 12-16 gram, Poria 12-16 gram, Radix Glycyrrhizae 3-6 gram, Mel 15-25 gram.
Be preferably: Fructus Fici fresh fruit 600 grams, Radix Codonopsis 15 grams, the Rhizoma Atractylodis Macrocephalae 10 grams, the Radix Astragali 15 grams, Poria 15 grams, Radix Glycyrrhizae 5 grams, Mel 20 grams.
Each component consumption of the present invention is the consumption of 1000 milliliters of oral liquids.Described Fructus Fici consumption is as the criterion with fresh fruit, and the Fructus Fici fresh fruit can substitute with the Fructus Fici dry fruit, and Fructus Fici dry fruit consumption is 15% of a fresh fruit consumption.
Medicine of the present invention can adopt the conventional method of Chinese medicine preparation to be prepared into any conventional oral preparations, comprises syrup, dissolved granule, and pill etc., but these can not be used to limit protection scope of the present invention.
Medicine of the present invention has invigorating the stomach and promoting bowel movement, subduing swelling and detoxicating, and functions such as invigorating the spleen and replenishing QI are used for the treatment of stomach anal and intestinal diseases such as stomachache, flatulence, acid regurgitation, constipation, hemorrhoid, dysentery.
The specific embodiment
Below further sets forth the beneficial effect of medicine of the present invention by testing example, these are tested is that the clinical observation on the therapeutic effect of medicine of the present invention (to call the positive stomach oral liquid of bowel relieving in the following text) is tested.
[test example 1]
The clinical observation that Drug therapy acute or chronic gastritis of the present invention, gastroduodenal are lost infections.
1, physical data
Accept patient's 158 examples for medical treatment, male 107 people, women 46 people, age 18-62 year.Clinical manifestation is upper abdomen distending pain, acid regurgitation, inappetence.Course of disease two weeks to 6 year.
2, Therapeutic Method
Day obeys three times, each 30-50 milliliter.7 days is a course of treatment, serve on 14 days.
3, efficacy assessment standard
Cure: malaise symptoms complete obiterations such as stomachache, flatulence, acid regurgitation, there is not recurrence in 3 years.
Produce effects: in clothes backs half an hour to seven day.Stomachache, expand, malaise symptoms complete obiteration such as acid.There is recurrence to continue to take this medicine in half a year.
Effectively: stomachache, expand, acid is clearly better or obviously alleviate and need often take this medicine.
Invalid: stomachache, expand, malaise symptoms such as acid regurgitation do not have obvious improvement, uses the other medicines treatment instead.
Therapeutic outcome sees Table 1:
The observation of curative effect of table 1 after treatment
Annotate: treatment time be in February, 2 000 to May, following up a case by regular visits to final time is March 2004.
In 14 days treatment, with positive stomach oral liquid treatment 158 people of bowel relieving, the result cures 75 people in a word.Produce effects 52 people, effective 20 people, invalid 11 people.Cure 47.5%, produce effects 32.9%, effective 12.7%, total effective rate 93.0%.
[test example 2]
Drug therapy constipation of the present invention, the clinical observation of hemorrhoid
1, physical data
Treatment patient 96 examples, hemorrhoid patients 59 people wherein, male 46 people, women 13 people, constipation patient 37 people, male 19 people, women 18 people, age 21-63 year.Clinical manifestation is malaise symptoms such as constipation, bob are expanded, defecation pain, bleeding hemorrhoids.Course of disease 1-10.
2, Therapeutic Method
Day obeys three times, each 40 milliliters, serve on 7 days.
3, efficacy assessment standard
Produce effects: defecate in 12 hours and recover normal, the pain due to hemorrhoid stopped bleeding in the clothes back.All malaise symptoms complete obiterations in the twenty four hours are observed and were not had recurrence in three months.
Effectively: malaise symptoms makes moderate progress in the clothes back 12 hours, malaise symptoms complete obiteration in three days, and the recurrence intermission prolongs, and need often take this medicine.
Invalid: all malaise symptoms do not have obvious improvement, do not reach effective standard person.
Therapeutic outcome sees Table 2:
The observation of curative effect of table 2 after treatment
In 7 days treatment, with positive stomach oral liquid treatment 96 examples of bowel relieving, produce effects 60 people as a result, effective 33 people, invalid 3 people.Produce effects 62.5%, effective 34.4%, total effective rate 96.9%.
[test example 3]
Medicine of the present invention is used for the treatment of diarrhoea, the clinical observation of dysentery.
1, physical data
Accept patient's 51 examples for medical treatment, 38 examples of wherein suffering from diarrhoea, dysentery 13 examples, male 40 people, women 11 people, age 7-50 year.Clinical manifestation is a hypogastralgia, and pus and blood is just arranged, and it is more than to have loose bowels, and chronic diarrhea is not healed.Course of disease 1-10 days.
2, Therapeutic Method
Day obeys three times, each 30 milliliters.Serve on two days.
3, efficacy assessment standard
Produce effects: obey that dysentery stops in back five minutes, malaise symptoms obviously disappears or disappears substantially, all symptom complete obiterations in two hours.(need not to continue to take medicine) serve on two days in order to consolidate curative effect.
Effectively: clothes back interior all malaise symptoms half an hour make moderate progress healing person in two days.
Invalid: clothes back symptom on the same day does not have obvious improvement, does not reach effective standard person.
4, therapeutic outcome sees Table 3:
The observation of curative effect of table 3 after treatment
In treatment in two days, with positive stomach oral liquid treatment 51 people of bowel relieving produce effects 36 people as a result, effective 11 people, invalid 4 people, obvious effective rate 70.1%, effective 21.6%, total effective rate 92.2%.
Claims (7)
1. a medicine for the treatment of the stomach anal and intestinal disease is characterized in that it mainly is to be made by the following raw materials in weight medicine: Fructus Fici fresh fruit 400-700 gram, Mel 15-25 gram and Radix Glycyrrhizae 3-6 gram.
2. according to the medicine of claim 1, wherein the consumption of each crude drug is: Fructus Fici fresh fruit 600 grams, Mel 20 grams and Radix Glycyrrhizae 5 grams.
3. according to the described medicine of claim 1, wherein crude drug also has: Radix Codonopsis 12-16 gram, Rhizoma Atractylodis Macrocephalae 8-12 gram.
4. according to the described medicine of claim 3, wherein each amounts of components is: Fructus Fici fresh fruit 600 grams, Radix Codonopsis 15 grams, the Rhizoma Atractylodis Macrocephalae 10 grams, Radix Glycyrrhizae 5 grams and Mel 20 grams.
5. according to the described medicine of claim 3, wherein also have in the crude drug: Radix Astragali 12-16 gram, Poria 12-16 gram.
6. according to the described medicine of claim 5, wherein the consumption of each component is: Fructus Fici fresh fruit 600 grams, Radix Codonopsis 15 grams, the Radix Astragali 15 grams, the Rhizoma Atractylodis Macrocephalae 10 grams, Poria 15 grams, Mel 20 grams and Radix Glycyrrhizae 5 grams.
7. according to the arbitrary described medicine of claim 1-6, it is characterized in that: the Fructus Fici fresh fruit can substitute with the Fructus Fici dry fruit, and Fructus Fici dry fruit consumption is 15% of a fresh fruit.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100257036A CN100387256C (en) | 2004-06-24 | 2004-06-24 | Medicine for treating gastric, anal and intestinal diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100257036A CN100387256C (en) | 2004-06-24 | 2004-06-24 | Medicine for treating gastric, anal and intestinal diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1712029A CN1712029A (en) | 2005-12-28 |
| CN100387256C true CN100387256C (en) | 2008-05-14 |
Family
ID=35717937
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004100257036A Expired - Fee Related CN100387256C (en) | 2004-06-24 | 2004-06-24 | Medicine for treating gastric, anal and intestinal diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100387256C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101584750B (en) * | 2009-07-10 | 2011-06-29 | 山东大学威海分校 | Compound fig preparation |
| CN107773698A (en) * | 2016-08-29 | 2018-03-09 | 朱玉龙 | A kind of oral liquid for treating human stomach anorectal disease |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1103269A (en) * | 1993-12-01 | 1995-06-07 | 付耀华 | Fig juice and its producing method |
| CN1408383A (en) * | 2001-09-27 | 2003-04-09 | 张丽 | Pure traditional Chinese medicine preparation for curing gastroinstestinal cancer and preparing method |
-
2004
- 2004-06-24 CN CNB2004100257036A patent/CN100387256C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1103269A (en) * | 1993-12-01 | 1995-06-07 | 付耀华 | Fig juice and its producing method |
| CN1408383A (en) * | 2001-09-27 | 2003-04-09 | 张丽 | Pure traditional Chinese medicine preparation for curing gastroinstestinal cancer and preparing method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1712029A (en) | 2005-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101766802B (en) | Chinese medicine composite for treatment of acute gastroenteritis and preparation method thereof | |
| CN101874874B (en) | Chinese medicinal preparation for treating helicobacter pylori concerned chronic gastritis and preparation method thereof | |
| CN102441081B (en) | Medicament for treating gout and its preparation method | |
| CN102698123A (en) | Traditional Chinese medicinal composition for treating transmissible gastroenteritis of swine, feed, preparation method and application thereof | |
| CN103623358B (en) | A kind of Chinese medicine decoction for the treatment of acute, chronic pharyngitis | |
| CN103263615A (en) | Traditional Chinese medicine preparation for treating stomach illness, enteritis and cholecystitis and preparation method thereof | |
| CN104225441A (en) | Traditional Chinese medicine composition for treating stomach trouble and preparation method of granules and capsules of traditional Chinese medicine composition | |
| CN102188685B (en) | Externally-applied traditional Chinese medicine powder for treating diarrhea type irritable bowel syndrome and preparation method thereof | |
| CN100457170C (en) | A Medicine for treatment of gastrointestinal diseases | |
| CN104352920A (en) | Digestion-helping and stomach-conditioning traditional Chinese medicinal composition | |
| CN101810823B (en) | Chinese medicinal composition for treating renal cyst diseases and use of preparing medicine | |
| CN101036717B (en) | Orally taken type Chinese traditional medicine combination for curing irritable bowel syndrome | |
| CN102000238B (en) | Martianus dermestoides capsule and preparation method | |
| CN103585585B (en) | A kind of Chinese medicine composition for the treatment of choledocholithiasis and preparation method thereof | |
| CN105832991A (en) | Traditional Chinese medicine composition for treating gastritis | |
| CN102430105A (en) | Traditional Chinese medicine composite for treating chronic gastritis | |
| CN100387256C (en) | Medicine for treating gastric, anal and intestinal diseases | |
| CN101700390B (en) | Oral traditional Chinese medicine composition for treating fatty liver | |
| CN108888735B (en) | Traditional Chinese medicine composition for treating chronic constipation | |
| CN104001070A (en) | Traditional Chinese medicine composition for treating constipation | |
| CN102145143A (en) | Pharmaceutical composition for treatment of gastritis and preparation method of pharmaceutical composition | |
| CN101028421B (en) | Chinese medicine for treating chronic kidney failure | |
| CN104940508A (en) | Chinese herba preparation for treating adhesive intestinal obstruction | |
| CN104225016A (en) | Drug composition for treating spleen and stomach deficiency type chronic atrophic gastritis | |
| CN104383403A (en) | Traditional Chinese medicinal composition for treating chronic gastritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080514 Termination date: 20190624 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |